Impact of Cytogenetic Risk on Outcomes of Non-T-Cell-Depleted Haploidentical Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia.
Nagler A, Labopin M, Dholaria B, Ciceri F, Fraccaroli A, Blaise D, Fanin R, Bruno B, Forcade E, Vydra J, Chevallier P, Bulabois CE, Jindra P, Bornhäuser M, Canaani J, Sanz J, Savani BN, Spyridonidis A, Giebel S, Brissot E, Bazarbachi A, Esteve J, Mohty M.
Nagler A, et al. Among authors: chevallier p.
Transplant Cell Ther. 2022 Nov;28(11):773.e1-773.e8. doi: 10.1016/j.jtct.2022.08.018. Epub 2022 Aug 27.
Transplant Cell Ther. 2022.
PMID: 36031079
Free article.